Get started
Author

Mitsuro Fukuhara

Observed names: Fukuhara, Mitsuro, MITSURO FUKUHARA
ORCID: 0000-0002-8122-0691
Observed ORCID: 0000-0002-8122-0691
OpenAlex ID: A5016322291
Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non–Small Cell Lung Cancer: Brief Report
2018 · Yuki Owada-Ozaki, Satoshi Muto, et al. · Journal of Thoracic Oncology · 170
Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer
2013 · Hiroyuki Suzuki, Mitsuro Fukuhara, et al. · Journal of Translational Medicine · 78
PDF
Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers
2023 · Satoshi Muto, Akio Enta, et al. · Biomedicines · 66
PDF
Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer
2019 · Yuki Ozaki, Satoshi Muto, et al. · Cancer Immunology Immunotherapy · 44
PDF
Nivolumab-related severe thrombocytopenia in a patient with relapsed lung adenocarcinoma: a case report and review of the literature
2019 · Takeo Hasegawa, Yuki Ozaki, et al. · Journal of Medical Case Reports · 42
PDF
The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study
2021 · Mitsuro Fukuhara, Satoshi Muto, et al. · Cancer Immunology Immunotherapy · 37
Prognostic Impact of Hypoxia-InduciblemiRNA-210in Patients with Lung Adenocarcinoma
2015 · Jun Osugi, Yuka Kimura, et al. · Journal of Oncology · 34
PDF
FDG-PET in the evaluation of response to nivolumab in recurrent non-small-cell lung cancer
2016 · Mitsunori Higuchi, Yuki Owada, et al. · World Journal of Surgical Oncology · 28
PDF
Pulmonary Resection for Metastatic Gastric Cancer
2016 · Yoshihito Iijima, Hirohiko Akiyama, et al. · Annals of Thoracic and Cardiovascular Surgery · 28
PDF
Tumor β‑catenin expression is associated with immune evasion in non‑small cell lung cancer with high tumor mutation burden
2021 · Satoshi Muto, Yuki Ozaki, et al. · Oncology Letters · 24
PDF
Clinical significance of expanded Foxp3+ Helios− regulatory T cells in patients with non-small cell lung cancer
2015 · SATOSHI MUTO, YUKI OWADA, et al. · International Journal of Oncology · 24
PDF
Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)
2021 · Hironori Takagi, Songji Zhao, et al. · Lung Cancer · 23
PDF
The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial
2017 · Takuya Inoue, Hironori Takagi, et al. · Trials · 21
PDF
Clinical and pathological aspects of microscopic thymoma with myasthenia gravis and review of published reports
2017 · Mitsuro Fukuhara, Mitsunori Higuchi, et al. · Journal of Thoracic Disease · 16
PDF
Serum Nitric Oxide as a Predictive Biomarker for Bevacizumab in Non-small Cell Lung Cancer Patients
2017 · SATOSHI MUTO, HIRONORI TAKAGI, et al. · Anticancer Research · 14
PDF
Efficacy and tolerability of nanoparticle albumin-bound paclitaxel in combination with carboplatin as a late-phase chemotherapy for recurrent and advanced non-small-cell lung cancer: A multi-center study of the Fukushima lung cancer association group of surgeons
2017 · Mitsunori Higuchi, Hironori Takagi, et al. · Oncology Letters · 14
Anomalous Systemic Arterial Supply to the Basal Segments of the Lung
2013 · MITSUNORI HIGUCHI, MASAYUKI CHIDA, et al. · FUKUSHIMA JOURNAL OF MEDICAL SCIENCE · 14
PDF
Abnormal branch of right pulmonary artery (A7): a case report and literature review
2016 · Maiko Atari, Yuki Nakajima, et al. · Surgical Case Reports · 12
Family with sequence similarity 83, member�B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild‑type epidermal growth factor receptor
2017 · Takumi Yamaura, Junji Ezaki, et al. · Oncology Letters · 10
PDF
Genetic alterations in epidermal growth factor receptor‑tyrosine kinase inhibitor‑na�ve non‑small cell lung carcinoma
2020 · Takumi Yamaura, Satoshi Muto, et al. · Oncology Letters · 7
PDF
Comparison of surgical outcomes after pneumonectomy and pulmonary function-preserving surgery for non-small cell lung cancer
2018 · Mitsunori Higuchi, Hironori Takagi, et al. · FUKUSHIMA JOURNAL OF MEDICAL SCIENCE · 7
PDF
An extremely rare case report of surgery of lung cancer with the absence of azygos vein
2016 · Maiko Atari, Yuki Nakajima, et al. · Surgical and Radiologic Anatomy · 7
Correlation between mutation burden of tumor and immunological/clinical parameters in considering biomarkers of immune checkpoint inhibitors for non-small cell lung cancer (NSCLC).
2017 · Yuki Owada, Satoshi Muto, et al. · Journal of Clinical Oncology · 6
Thoracoscopic resection of posterior mediastinal paraganglioma: perioperative management and surgical tips
2022 · Yuki Matsumura, Mitsuro Fukuhara, et al. · Journal of Cardiothoracic Surgery · 5
PDF
Epidermal growth factor receptor mutation status is strongly associated with smoking status in patients undergoing surgical resection for lung adenocarcinoma
2017 · Yuki Matsumura, Yuki Owada, et al. · Interactive Cardiovascular and Thoracic Surgery · 5
Works count: 63
Citation count: 769
H-index: 14
I10-index: 19
Year
Topic
Type